acetylcysteine has been researched along with omeprazole in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Ammann, R; Flury, R; Meyenberger, C; Wirth, HP; Wüst, J; Zala, G | 1 |
| Chen, X; Xie, Z; Zhong, D | 1 |
| Krishna, M; Lalmuanpuii, J | 1 |
| Demirturk, L; Gurbuz, AK; Ozel, AM; Ozturk, R; Yazgan, Y; Yildirim, S | 1 |
| Chen, X; Hao, J; Hao, X; Lee, M; Liu, B; Reuhl, KR; Yang, CS; Zhang, B | 1 |
| Bali, M; Gill, NS; Muthuraman, A; Sharma, PD; Sood, S | 1 |
| Araújo, JH; Cardoso, MR; Dal-Pizzol, F; Daufenbach, JF; Gonçalves, CL; Petronilho, FC; Rezin, GT; Roesler, R; Schwartsmann, G; Streck, EL | 1 |
| Amali, A; Dabirmoghaddam, P; Hejazi, M; Motiee Langroudi, M; Samavati Fard, MR; Sharifian Razavi, M | 1 |
| Hu, Z; Peng, Y; Shi, J; Su, M; Sun, C; Zhao, Y; Zheng, J | 1 |
1 review(s) available for acetylcysteine and omeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for acetylcysteine and omeprazole
| Article | Year |
|---|---|
[Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine].
Topics: Acetylcysteine; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1994 |
Effect of N-acetyl cysteine on Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
The effect of N-acetyl cysteine on laryngopharyngeal reflux.
Topics: Acetylcysteine; Adult; Female; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Omeprazole; Placebos; Proton Pump Inhibitors | 2013 |
13 other study(ies) available for acetylcysteine and omeprazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water | 2018 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Metabolism of pantoprazole involving conjugation with glutathione in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimidazoles; Chromatography, High Pressure Liquid; Glutathione; Magnetic Resonance Spectroscopy; Male; Omeprazole; Pantoprazole; Pyridines; Rats; Rats, Wistar; Spectrometry, Mass, Electrospray Ionization; Sulfoxides | 2005 |
Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetylcysteine; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Expectorants; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2005 |
Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.
Topics: Acetylcysteine; Adenocarcinoma; alpha-Tocopherol; Animals; Disease Models, Animal; Esophageal Neoplasms; Gastroesophageal Reflux; Hydrogen-Ion Concentration; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Vitamin A | 2009 |
Role of 7,8-dimethoxycoumarin in anti-secretary and anti-inflammatory action on pyloric ligation-induced gastritis in rats.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Citrus; Coumarins; Gastritis; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Omeprazole; Pylorus; Rats; Rats, Wistar | 2010 |
Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bombesin; Drug Therapy, Combination; Electron Transport; Electron Transport Complex II; Electron Transport Complex III; Gastric Mucosa; Gastritis; Indomethacin; Male; Mitochondria; Omeprazole; Peptide Fragments; Proton Pump Inhibitors; Rats; Rats, Wistar; Receptors, Bombesin; Severity of Illness Index; Stomach; Stomach Ulcer | 2011 |
Evidence for Metabolic Activation of Omeprazole In Vitro and In Vivo.
Topics: Acetylcysteine; Activation, Metabolic; Animals; Benzoquinones; Cytochrome P-450 CYP3A; Glutathione; Humans; Imines; Ketoconazole; Microsomes, Liver; Omeprazole; Proton Pump Inhibitors; Rats | 2022 |